With the analysis among 5,371 patents, we discovered top 446 key players by total patent application. F. Hoffmann-La Roche Ltd., Chugai Pharmaceutical Co., Ltd., Shanghai Human Genome Research Center are dominant in this area. They take 5.12% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 96
Shanghai Human Genome Research Center
Basel-Stadt, Switzerland
Patent: 70
Tokyo-to, Japan
Patent: 70
Ganymed Pharmaceuticals AG
Rheinland-Pfalz, Germany
Patent: 62
California, United States
Patent: 61
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 54
Indiana, United States
Patent: 51
With the analysis among 128 patents, we discovered top 33 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Combined Therapeutics, Inc., ImmunoMet Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 12
ImmunoMet Therapeutics, Inc.
Texas, United States
Patent: 12
California, United States
Patent: 10
Beijing Shi, China
Patent: 6
Algen Biotechnologies, Inc.
California, United States
Patent: 6
Biosplice Therapeutics, Inc.
California, United States
Patent: 5
Ashvattha Therapeutics Inc
California, United States
Patent: 5
With the analysis among related 4,030 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Zhejiang University, China Pharmaceutical University, F. Hoffmann-La Roche Ltd. take 3.52% of patent filing during this period.
Zhejiang Sheng, China
Patent: 48
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 47
F. Hoffmann-La Roche Ltd.
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 37
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 24
California, United States
Patent: 24
Academy of Military Medical Sciences
Guizhou Sheng, China
Patent: 23
With the analysis among related 4,030 patents in last 5 years, we discover 234 new entrants. Lepidyne Co., Ltd., The Naval Medical University of PLA, Remedy Plan, Inc. are the most active new entrants in this area.
The Naval Medical University of PLA
undefined undefined
Patent: 18
United Arab Emirates University
United Arab Emirates
Patent: 14
Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Liaoning Sheng, China
Patent: 13
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Fujian Sanan Sino-Science Photobiotech Co., Ltd
Fujian Sheng, China
Patent: 11
Tianjin University of Science & Technology
Tianjin Shi, China
Patent: 11
The Second Hospital of Shandong University
undefined undefined
Patent: 11
Gyeonggi-do, South Korea
Patent: 10
With the analysis among 4,390 patents, we discovered top 297 universities and scientific research institutions by total patent application. The Second Military Medical University, Fudan University, Zhejiang University are dominant in this area. They take 6.77% of the total patent filing.
The Second Military Medical University
Shanghai Shi, China
Patent: 96
Shanghai Shi, China
Patent: 89
Zhejiang Sheng, China
Patent: 89
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 73
Shandong Sheng, China
Patent: 45
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 45
Guangdong Sheng, China
Patent: 43
The Johannes Gutenberg University of Mainz
Rheinland-Pfalz, Germany
Patent: 37
Beijing Shi, China
Patent: 35
Jiangsu Sheng, China
Patent: 35